These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 31299296)

  • 1. The anthelmintic oxyclozanide restores the activity of colistin against colistin-resistant Gram-negative bacilli.
    Ayerbe-Algaba R; Gil-Marqués ML; Miró-Canturri A; Parra-Millán R; Pachón-Ibáñez ME; Jiménez-Mejías ME; Pachón J; Smani Y
    Int J Antimicrob Agents; 2019 Oct; 54(4):507-512. PubMed ID: 31299296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant
    Ayerbe-Algaba R; Gil-Marqués ML; Jiménez-Mejías ME; Sánchez-Encinales V; Parra-Millán R; Pachón-Ibáñez ME; Pachón J; Smani Y
    Front Cell Infect Microbiol; 2018; 8():348. PubMed ID: 30338245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.
    Domalaon R; Okunnu O; Zhanel GG; Schweizer F
    J Antibiot (Tokyo); 2019 Aug; 72(8):605-616. PubMed ID: 31028351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repositioning rafoxanide to treat Gram-negative bacilli infections.
    Miró-Canturri A; Ayerbe-Algaba R; Villodres ÁR; Pachón J; Smani Y
    J Antimicrob Chemother; 2020 Jul; 75(7):1895-1905. PubMed ID: 32240294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diclofenac Sodium Restores the Sensitivity of Colistin-Resistant Gram-Negative Bacteria to Colistin.
    Fu Q; Liu S; Hu P; Chen H; Zheng J; Shi S; Xu M; Zhou T; Sun Y
    ACS Infect Dis; 2024 Aug; 10(8):2860-2869. PubMed ID: 39073350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates.
    Vidaillac C; Benichou L; Duval RE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4856-61. PubMed ID: 22751540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the colistin-rifampicin combination against colistin-resistant, carbapenemase-producing Gram-negative bacteria.
    Nastro M; Rodríguez CH; Monge R; Zintgraff J; Neira L; Rebollo M; Vay C; Famiglietti A
    J Chemother; 2014 Aug; 26(4):211-6. PubMed ID: 24070502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservation of Acquired Colistin Resistance in Gram-Negative Bacteria.
    Lee JY; Choi MJ; Choi HJ; Ko KS
    Antimicrob Agents Chemother; 2016 Jan; 60(1):609-12. PubMed ID: 26459897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates.
    Choi MJ; Park YK; Peck KR; Ko KS
    Int J Antimicrob Agents; 2014 Nov; 44(5):475-6. PubMed ID: 25443890
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
    Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
    Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
    Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
    Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
    Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 14. Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus.
    Rajamuthiah R; Fuchs BB; Conery AL; Kim W; Jayamani E; Kwon B; Ausubel FM; Mylonakis E
    PLoS One; 2015; 10(4):e0124595. PubMed ID: 25897961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
    Vila-Farrés X; Callarisa AE; Gu X; Savage PB; Giralt E; Vila J
    Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Colistin-Resistant, Gram-Negative Bacteria to Antimicrobial Peptides and Ceragenins.
    Hashemi MM; Rovig J; Weber S; Hilton B; Forouzan MM; Savage PB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the in vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care centre in Western Turkey.
    Ece G; Samlioglu P; Atalay S; Kose S
    Infez Med; 2014 Mar; 22(1):36-40. PubMed ID: 24651089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Colistin Resistance among Gram-Negative Rods and Klebsiella pneumoniae Isolates.
    Richter SE; Miller L; Uslan DZ; Bell D; Watson K; Humphries R; McKinnell JA
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29976595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates.
    Choi MJ; Ko KS
    J Antimicrob Chemother; 2014 Jan; 69(1):275-7. PubMed ID: 23997018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.